112 related articles for article (PubMed ID: 17974978)
1. p53 determines multidrug sensitivity of childhood neuroblastoma.
Xue C; Haber M; Flemming C; Marshall GM; Lock RB; MacKenzie KL; Gurova KV; Norris MD; Gudkov AV
Cancer Res; 2007 Nov; 67(21):10351-60. PubMed ID: 17974978
[TBL] [Abstract][Full Text] [Related]
2. Pyrazoloacridine is active in multidrug-resistant neuroblastoma cell lines with nonfunctional p53.
Keshelava N; Tsao-Wei D; Reynolds CP
Clin Cancer Res; 2003 Aug; 9(9):3492-502. PubMed ID: 12960142
[TBL] [Abstract][Full Text] [Related]
3. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
[TBL] [Abstract][Full Text] [Related]
4. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
5. Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents.
Gangopadhyay S; Jalali F; Reda D; Peacock J; Bristow RG; Benchimol S
Exp Cell Res; 2002 Apr; 275(1):122-31. PubMed ID: 11925110
[TBL] [Abstract][Full Text] [Related]
6. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
7. The dual role of mutant p53 protein in chemosensitivity of human cancers.
Mueller H; Eppenberger U
Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
[TBL] [Abstract][Full Text] [Related]
8. Expression of C-terminal deleted p53 isoforms in neuroblastoma.
Goldschneider D; Horvilleur E; Plassa LF; Guillaud-Bataille M; Million K; Wittmer-Dupret E; Danglot G; de Thé H; Bénard J; May E; Douc-Rasy S
Nucleic Acids Res; 2006; 34(19):5603-12. PubMed ID: 17028100
[TBL] [Abstract][Full Text] [Related]
9. Essential role for p53 and caspase-9 in DNA damaging drug-induced apoptosis in neuroblastoma IMR32 cells.
Li T; Cui ZB; Ke XX; Tan J; Li FF; Li T; Wang XW; Cui HJ
DNA Cell Biol; 2011 Dec; 30(12):1045-50. PubMed ID: 21612408
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of p53 in chemotherapy resistance of lung cancer cell lines.
Breen L; Heenan M; Amberger-Murphy V; Clynes M
Anticancer Res; 2007; 27(3A):1361-4. PubMed ID: 17593631
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Keshelava N; Zuo JJ; Chen P; Waidyaratne SN; Luna MC; Gomer CJ; Triche TJ; Reynolds CP
Cancer Res; 2001 Aug; 61(16):6185-93. PubMed ID: 11507071
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
[TBL] [Abstract][Full Text] [Related]
13. Insights into aging obtained from p53 mutant mouse models.
Dumble M; Gatza C; Tyner S; Venkatachalam S; Donehower LA
Ann N Y Acad Sci; 2004 Jun; 1019():171-7. PubMed ID: 15247009
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
[TBL] [Abstract][Full Text] [Related]
15. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
16. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
17. Human glioblastoma U87MG cells transduced with a dominant negative p53 (TP53) adenovirus construct undergo radiation-induced mitotic catastrophe.
Ianzini F; Domann FE; Kosmacek EA; Phillips SL; Mackey MA
Radiat Res; 2007 Aug; 168(2):183-92. PubMed ID: 17638400
[TBL] [Abstract][Full Text] [Related]
18. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
19. Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells.
Lim S; Hung AC; Porter AG
Mol Cancer Res; 2009 Jan; 7(1):55-66. PubMed ID: 19147537
[TBL] [Abstract][Full Text] [Related]
20. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]